title: [Clinicopathological confrontation. Was the skin cancer eradicated?].
abstract: Distinguishing complete removal of a skin cancer and its partial destruction is frequently requested by the clinicians and their patients. The information is awaited from the laboratory, but it is not always correctly interpreted by the information-seekers. The factors influencing this assessment include the combination of the nature of the antineoplastic therapy, the sampling modality of the area to be examined, and the quality of the dermatopathology procedure. In addition, the possibility of neoplastic regression linked to scarring or, conversely, the existence of a possible field cancerisation should be taken into consideration.
authors.affiliation: Service de Dermatopathologie, CHU du Sart Tilman, Liège, Belgique.
authors.forename: J E
authors.initials: JE
authors.lastname: Arrese
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
authors.forename: M
authors.initials: M
authors.lastname: Ruiz Ballon
authors.forename: P
authors.initials: P
authors.lastname: Quatresooz
mesh_terms: D002280:Basal Cell Carcinoma / Q000473:pathology; D002921:Cicatrix / Q000473:pathology; D006801:Humans; D015580:Mohs Surgery; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome